{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:53Z","timestamp":1792601513487,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijcard.2019.09.065","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:19:18Z","timestamp":1570558758000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of cardiovascular pharmacotherapies on incident dementia in patients with atrial fibrillation: A cohort study of all patients above 45 years diagnosed with AF in hospitals in Sweden"],"prefix":"10.1016","volume":"297","author":[{"given":"Per","family":"W\u00e4ndell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel C.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.09.065_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/0028-3886.149384","article-title":"Assessment of risk factors for earlier onset of sporadic Alzheimer\u2019s disease dementia","volume":"62","author":"de Oliveira","year":"2014","journal-title":"Neurol. India"},{"key":"10.1016\/j.ijcard.2019.09.065_bib2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective","volume":"11","author":"Baumgart","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ijcard.2019.09.065_bib3","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.09.065_bib4","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/eurheartj\/ehx208","article-title":"Atrial fibrillation as a risk factor for cognitive decline and dementia","volume":"38","author":"Singh-Manoux","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.065_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2013.10.063","article-title":"Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system","volume":"170","author":"Forslund","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib6","unstructured":"SBU. Dementia \u2013 Etiology and Epidemiology. Stockholm, 2008. Report No 172E\/1."},{"key":"10.1016\/j.ijcard.2019.09.065_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11357-018-0029-8","article-title":"The association between relevant comorbidities and dementia in patients with atrial fibrillation","volume":"40","author":"Wandell","year":"2018","journal-title":"Geroscience"},{"key":"10.1016\/j.ijcard.2019.09.065_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arcmed.2019.05.007","article-title":"Association between relevant Co-morbidities and dementia with atrial fibrillation-A national study","volume":"50","author":"Wandell","year":"2019","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijcard.2019.09.065_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ijcard.2019.09.065_bib11","first-page":"CD004034","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2019.09.065_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-2012-120748","article-title":"Walking the cognitive \u201cminefield\u201d between high and low blood pressure","volume":"32","author":"Kennelly","year":"2012","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ijcard.2019.09.065_bib13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/HJH.0000000000000868","article-title":"Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies","volume":"34","author":"Tully","year":"2016","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ijcard.2019.09.065_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident alzheimer disease: the cache county study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib15","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer\u2019s disease: the Cache County Study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijcard.2019.09.065_bib16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ijcard.2019.09.065_bib17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jgs.13627","article-title":"Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to alzheimer\u2019s disease","volume":"63","author":"Wharton","year":"2015","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2019.09.065_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/ijcp.12626","article-title":"Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer\u2019s disease: a meta-analysis","volume":"69","author":"Ye","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2019.09.065_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2016.05.003","article-title":"Renin-angiotensin system blockade use and risks of cognitive decline and dementia: a meta-analysis","volume":"624","author":"Zhuang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijcard.2019.09.065_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","article-title":"Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus","volume":"8","author":"Johnson","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ijcard.2019.09.065_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2017.07.015","article-title":"Effects of different antihypertensive medication groups on cognitive function in older patients: a systematic review","volume":"46","author":"Stuhec","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.ijcard.2019.09.065_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2018.07.106","article-title":"Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation","volume":"272","author":"Wandell","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib23","first-page":"CD003160","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2019.09.065_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.21037\/atm.2018.06.43","article-title":"Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis","volume":"6","author":"Zhu","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijcard.2019.09.065_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2016.3783","article-title":"Sex and race differences in the association between statin use and the incidence of alzheimer disease","volume":"74","author":"Zissimopoulos","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ijcard.2019.09.065_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcpt.12613","article-title":"The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature","volume":"119","author":"Wallerstedt","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2019.09.065_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10741-011-9265-z","article-title":"Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment","volume":"17","author":"Carubelli","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2019.09.065_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/clc.20771","article-title":"Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue","volume":"33","author":"Chiong","year":"2010","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00228-012-1395-2","article-title":"Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study","volume":"69","author":"Wandell","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","article-title":"Less dementia with oral anticoagulation in atrial fibrillation","volume":"39","author":"Friberg","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.065_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jech.2003.008466","volume":"58","author":"Delgado-Rodriguez","year":"2004","journal-title":"Bias. J Epidemiol Community Health."},{"key":"10.1016\/j.ijcard.2019.09.065_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of alzheimer disease at national Institute on aging alzheimer disease Centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijcard.2019.09.065_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731934104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731934104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:43:33Z","timestamp":1759092213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731934104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"alternative-id":["S016752731934104X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.065","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cardiovascular pharmacotherapies on incident dementia in patients with atrial fibrillation: A cohort study of all patients above 45 years diagnosed with AF in hospitals in Sweden","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}